Transcranial laser therapy in acute stroke treatment: Results of neurothera effectiveness and safety trial 3, a phase III clinical end point device trial

Werner Hacke, Peter D. Schellinger, Gregory W. Albers, Natan M. Bornstein, Bjorn L. Dahlof, Rachael Fulton, Scott E. Kasner, Ashfaq Shuaib, Steven P. Richieri, Stephen G. Dilly, Justin Zivin, Kennedy R. Lees, Justin A. Zivin, Joseph Broderick, Anastasia Ivanova, Karen Johnston, Bo Norrving, Greg Albars, Andrei Alexandrov, David BrownPatrick Capone, David Chiu, Wayne Clark, Jack Cochran, Colin Deredyn, Thomas Devlin, William Hickling, George Howell, David Huang, Shazam Hussain, Sidney Mallenbaum, Majaz Moonis, Marshall Nash, Marilyn Rymer, Reid Taylor, Margaret Tremwel, Brian Buck, Julio Perez, Christian Gerloff, Bernd Greiwing, Martin Grond, Gerhard Hamman, Thomas Haarmeiter, Sebastian Jander, Martin Köhrmann, Martin Ritter, Peter Schallinger, Dietmar Schneider, Jan Sobesky, Thorsten Steiner, Helmuth Steinmetz, Roland Veltkamp, Christian Weimar, Franz Gruber, Bjorn Andersson, Lennart Welin, Didier Leys, Turgut Tatlisumak, Andreas Luft, Philippe Lyrer, Patrik Michel, Carlos Molina, Tomas Segura

Research output: Contribution to journal › Article › peer-review

78 Scopus citations

Fingerprint

Dive into the research topics of 'Transcranial laser therapy in acute stroke treatment: Results of neurothera effectiveness and safety trial 3, a phase III clinical end point device trial'. Together they form a unique fingerprint.

Medicine & Life Sciences